Drug · DIN 02473003
CUTAQUIG
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since February 15, 2018.
- Drug Identification Number (DIN)
- 02473003
- Company (DIN owner)
- Octapharma Pharmazeutika Produktionsges M B HVienna, Vienne, Austria
- Schedule
- Schedule d
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Immunoglobulins, normal human, for extravasc. adm J06BA01
- Class
- Human
- Record last updated
- May 13, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| IMMUNOGLOBULIN G (HUMAN) | 1.65 G | 10 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 15, 2018: NOC 20489New Drug Submission (NDS)
Other DINs named CUTAQUIG
- DIN 02472996 · Dormant
- DIN 02473011 · Dormant
- DIN 02473038 · Approved
- DIN 02473046 · Dormant
- DIN 02473054 · Dormant